Status:

COMPLETED

Can Short Latency Afferent Inhibition Give us Clues to Better DYT 1 Dystonia Treatments?

Lead Sponsor:

University of Florida

Collaborating Sponsors:

Brain and Spinal Cord Injury Research Trust Fund

Conditions:

DYT-1

DYT1

Eligibility:

All Genders

10-80 years

Brief Summary

This is a research study using transcranial magnetic stimulation (TMS) to investigate interactions between the sensory system and the motor cortex in primary generalized dystonia (DYT1 dystonia) subje...

Detailed Description

The cause of DYT1 dystonia is not clear. DYT1 dystonia symptoms include abnormal posture or repetitive twisting movements affecting one body part; in some patients, the entire body can twist and conto...

Eligibility Criteria

Inclusion

  • INCLUSION CRITERIA:
  • Between the ages of 10 and 80 years. (CONTROL SUBJECTS between 18-80 years)
  • Diagnosis and genetic test results confirming diagnosis of DYT1 dystonia.
  • Currently treated with medications and enrolled in evaluation process for DBS surgery to confirm candidacy - OR -
  • Previous DBS surgery
  • EXCLUSION CRITERIA:
  • Implanted pacemaker, medication pump, vagal stimulator, Transcutaneous electrical nerve stimulation (TENS) unit or ventriculoperitoneal shunt.
  • Family or personal history of medication refractory epilepsy.
  • Pregnancy: due to the frequent visits over a prolonged period and the lack of Information on the safety of TMS during pregnancy, pregnant women will not be eligible to participate in this study. Women of childbearing potential will be eligible to participate, provided that they are using adequate contraception during TMS treatments.
  • This study is accepting healthy volunteers, aged 18-80, as control subjects. Control subjects will not undergo DBS surgery.
  • EXCLUSION CRITERIA (as it applies to healthy control subjects):
  • Cannot have family history or personal history of medication refractory epilepsy

Exclusion

    Key Trial Info

    Start Date :

    May 1 2012

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    August 1 2016

    Estimated Enrollment :

    5 Patients enrolled

    Trial Details

    Trial ID

    NCT01435681

    Start Date

    May 1 2012

    End Date

    August 1 2016

    Last Update

    September 8 2016

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    UF Center for Movement Disorders and Neurorestoration

    Gainesville, Florida, United States, 32607